In CRC cells, it synergistically enhances paclitaxel-induced autophagy by increasing autophagosome formation—as indicated by elevated LC3-II/LC3-I ratios and SQSTM1/p62 degradation [64]. Here, SQSTM1 is linked to colorectal carcinoma.